Surgical Management of Parotid Hemangioma

Reinisch, John F.; Kim, Regina Y.; Harshbarger, Raymond J.; Meara, John G.

doi:10.1097/01.prs.0000122205.50329.e1

Cited by 32 publications

(16 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Surgery and deep intraparenchymal laser treatment of parotid hemangiomas has generally been avoided because of potential facial nerve injury. Although cheek skin and underlying tissue may return to normal, there is often permanent residual telangiectasia, tissue laxity and fibrofatty fullness of the cheek following involution of large parotid hemangiomas (1).…”

mentioning

confidence: 99%

Preoperative treatment of a parotid hemangioma with 100% ethyl alcohol

Emsen¹

2008

CAN J PLAST SURG

View full text Add to dashboard Cite

Hemangiomas are one of the most common childhood neoplasms, occurring in approximately 12% of infants younger than one year of age. The lesions typically appear shortly after birth, increase in size over the first year and characteristically regress over the next decade. Because hemangiomas can be visible during an important stage of a child's social development, numerous authors have pursued alternative treatment strategies to avoid or reduce this lengthy involution process. Unfortunately, no effective medical treatment has been reported for children with large, deforming hemangiomas of the parotid gland and overlying cheek. In the present case, a patient with a large parotid hemangioma was treated preoperatively with an intralesional injection of 100% ethyl alcohol solution to reduce the size of the mass. The mass was removed 28 days later with no major postoperative complications.Key Words: Ethyl alcohol; Hemangioma; Injection Le traitement préopératoire d'un hémangiome parotidien à l'aide d'alcool éthylique 100 % Les hémangiomes font partie des néoplasmes les plus courants chez l'enfant. On les observe chez environ 12 % des nourrissons de moins d'un an. D'ordinaire, les lésions se manifestent peu après la naissance, grossissent pendant la première année et régressent au cours des dix années suivantes. Puisque les hémangiomes peuvent être visibles pendant une phase importante du développement social de l'enfant, de nombreux auteurs ont recouru à des stratégies de traitement pour éviter ou raccourcir ce long processus d'involution. Malheureusement, on n'a déclaré aucun traitement médical efficace pour les enfants présentant un gros hémangiome déformant de la parotide et de la joue sus-jacente. Dans le présent cas, un patient ayant un gros hémangiome parotidien a subi un traitement préopératoire par injection d'une solution d'alcool éthylique 100 % dans la lésion afin de réduire la dimension de la masse. On a procédé à l'ablation de la masse 28 jours plus tard, sans complication postopératoire majeure.

show abstract

mentioning

confidence: 99%

Preoperative treatment of a parotid hemangioma with 100% ethyl alcohol

Emsen¹

2008

CAN J PLAST SURG

View full text Add to dashboard Cite

show abstract

“…In the past, small well-localized lesions were treated with intralesional corticosteroids, while systemic corticosteroids were indicated for large symptomatic hemangiomas [2, 6, 9]. Long-term systemic corticosteroid therapy is associated with serious side effects such as hypothalamic-pituitary-adrenal suppression, glucose intolerance, weight gain, hypokalemia, sodium and water retention, osteoporosis, and peptic ulcers.…”

Section: Discussionmentioning

confidence: 99%

“…For patients failing corticosteroids or who have a contraindication to corticosteroids, interferon alfa-2a or alfa-2b was considered in the past [2, 3, 6, 9]. However, interferon carries a small but substantial risk of serious neurologic complications, predominantly spastic diplegia, an unacceptable complication [6].…”

Section: Discussionmentioning

confidence: 99%

Involution of a Large Parotid Hemangioma with Oral Propranolol: An Illustrative Report and Review of the Literature

Mantadakis

Tsouvala²,

Deftereos³

et al. 2012

Case Reports in Pediatrics

View full text Add to dashboard Cite

Propranolol has emerged as a new treatment option for infantile hemangiomas. We describe a 20-month-old boy with a large right parotid hemangioma diagnosed at the age of 37 days. Starting at the age of 2.5 months, he received oral propranolol for 6.5 months. Although the mass regressed, it recurred when propranolol was discontinued. He was successfully retreated at the age of 11 months with propranolol for another 5.5 months without further recurrences. Treatment was tolerated well. Our paper and a review of the literature demonstrate that propranolol appears to be safe and effective for symptomatic infantile parotid gland hemangiomas.

show abstract

“…Proliferation is followed by a variable involutional phase which is complete in 60% of children by age 4 and 76% by age 7 [3]. During the involutional phase, the characteristic red cutaneous discoloration fades to more normal skin tones, whereas deeper components shrink and become fibrofatty tissue [4]. Despite involution, larger hemangiomas often leave a patient with severe deformity characterized by skin redundancy, excessive deep fibrofatty tissue, dermal atrophy and scarring.…”

Section: Introductionmentioning

confidence: 98%